Gilead reported revenues of $6.67 billion in the last reported quarter, representing a year-over-year change of -0.3%. EPS of $1.81 for the same period compares with -$1.32 a year ago.

Explore the exciting world of Gilead Sciences (NASDAQ: GILD) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends ...

Gilead Sciences Inc (Symbol: GILD) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a ...

Gilead reported revenues of $6.67 billion in the last reported quarter, representing a year-over-year change of -0.3%. EPS of $1.81 for the same period compares with -$1.32 a year ago.

In the latest trading session, Gilead Sciences (GILD) closed at $109.06, marking a -2.7% move from the previous day. This change lagged the S&P 500's daily loss of 0.4%. Meanwhile, the Dow lost 0. ...

In the latest trading session, Gilead Sciences (GILD) closed at $105.93, marking a -1.18% move from the previous day. Meanwhile, the Dow lost 0.25%, and the Nasdaq, a tech-heavy index, added 0.31%.

Gilead Sciences is currently sporting a Zacks Rank of #2 (Buy). The Zacks Consensus Estimate for GILD's full-year earnings has moved 0.7% higher within the past quarter.

(RTTNews) - Gilead Sciences, Inc. (GILD) Friday announced positive topline results from the Phase 3 ASCENT-03 study of Trodelvy in patients with first-line metastatic triple-negative breast cancer ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available today, for the August 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options become available today, for the September 2026 expiration. One of the key data points that goes into the price an option buyer is ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options begin trading this week, for the February 2026 expiration. One of the key inputs that goes into the price an option buyer is willing ...

Stock to Watch: Gilead Sciences (GILD) Headquartered in Foster City, CA, Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus (HIV).